Stocks making the biggest moves after hours: Pivotal Software, Progenics Pharmaceuticals and more

Pedestrians pass Pivotal Software Inc. signage displayed outside the New York Stock Exchange (NYSE) during the company's initial public offering (IPO) in New York, U.S., on Friday, April 20, 2018. 
Michael Nagle | Bloomberg | Getty Images
Pedestrians pass Pivotal Software Inc. signage displayed outside the New York Stock Exchange (NYSE) during the company's initial public offering (IPO) in New York, U.S., on Friday, April 20, 2018. 

Check out the companies making headlines after the bell:

Pivotal Software shares tumbled more than 20 percent in after-hours trading despite reporting second-quarter earnings numbers that beat on both the top and bottom line. The San Francisco-based company reported revenues of $164.4 million, higher than the $158.2 million analysts expected. The company also reported a loss of 6 cents per share, less than the 9 cents per share loss expected by analysts.

Progenics Pharmaceuticals stock dropped more than 16 percent in the extended session after being halted, following an announcement that the Phase 3 clinical trial for its prostate cancer imaging agent failed. "These top line Phase 3 results of 1404 are inconsistent with the prior Phase 2 data, which showed significantly higher sensitivity rates," said CEO Mark Baker.

Oxford Industries shares fell as much as 6 percent in the extended session after the company, which owns clothing brands including Lily Pulitzer and Tommy Bahama, reported second-quarter earnings. The company reported earnings per share of $1.83 according to Reuters, which was in line with analysts' estimates. The company also reported $302.6 million in revenue, according to Reuters, lower than the $306.1 million expected by analysts.

Tailored Brands stock rose nearly 7 percent in after-hours trading after the company reported second-quarter earnings. The company, which owns apparel brands Men's Wearhouse and Joseph A. Bank, reported earnings per share of $1.07 according to Dow Jones, higher than analysts' estimates of $1.06 per share. The company also reported $823.4 million in revenue according to Dow Jones, lower than the $828.4 million expected by analysts.